WTA
RMD icon

Washington Trust Advisors’s ResMed RMD Stock Holding History

Washington Trust Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.9M Sell
119,824
-2,741
-2% -$683K 2.17% 13
2025
Q4 		$29.5M Sell
122,565
-1,498
-1% -$383K 2.26% 14
2025
Q3 		$34M Sell
124,063
-3,910
-3% -$1.07M 2.58% 12
2025
Q2 		$33M Sell
127,973
-342
-0.3% -$81.6K 2.68% 11
2025
Q1 		$28.7M Sell
128,315
-368
-0.3% -$85.9K 2.55% 11
2024
Q4 		$29.4M Sell
128,683
-1,789
-1% -$431K 2.46% 12
2024
Q3 		$31.9M Sell
130,472
-1,614
-1% -$361K 2.74% 10
2024
Q2 		$25.3M Sell
132,086
-2,824
-2% -$573K 2.32% 13
2024
Q1 		$26.7M Sell
134,910
-1,473
-1% -$270K 2.45% 14
2023
Q4 		$23.5M Sell
136,383
-271
-0.2% -$41.6K 2.25% 14
2023
Q3 		$20.2M Buy
136,654
+6,851
+5% +$1.24M 2.07% 16
2023
Q2 		$28.4M Sell
129,803
-290
-0.2% -$64.6K 2.75% 9
2023
Q1 		$28.5M Sell
130,093
-892
-0.7% -$194K 2.9% 7
2022
Q4 		$27.3M Sell
130,985
-2,925
-2% -$643K 2.98% 7
2022
Q3 		$29.2M Sell
133,910
-3,403
-2% -$775K 2.74% 7
2022
Q2 		$28.8M Buy
137,313
+1,961
+1% +$417K 2.54% 8
2022
Q1 		$32.8M Sell
135,352
-1,042
-0.8% -$252K 2.33% 11
2021
Q4 		$35.5M Buy
+136,394
New +$35.4M 2.4% 9

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Washington Trust Advisors's RMD Position: Q1 2026 in Review

Washington Trust Advisors reduced its ResMed (RMD) stake by 2.2% in Q1 2026, selling an estimated $683K and leaving 119,824 shares worth $26.9M. The position accounts for 2.17% of the portfolio, ranked #13.

Washington Trust Advisors first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $35.5M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Washington Trust Advisors held 119,824 shares of ResMed worth $26.9M as of Q1 2026.
  • Washington Trust Advisors sold 2,741 ResMed shares in Q1 2026, an estimated $683K.
  • ResMed made up 2.17% of Washington Trust Advisors's portfolio in Q1 2026, its #13 holding.
  • Washington Trust Advisors first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Washington Trust Advisors's ResMed position peaked at $35.5M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.